3 employees
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
2017
$5.9M
from 4 investors over 4 rounds
Rodeo Therapeutics raised $5.9M on July 25, 2017
Investors: WATSON FUND, L.P., Washington Research Foundation, ARCH Venture Partners and WuXi AppTec